Risk assessment for the implementation of controlled human Schistosoma mansoni infection trials in Uganda. (2019)
Attributed to:
Immunomodulation and Vaccines
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.12688/aasopenres.12972.2
PubMed Identifier: 31819922
Publication URI: http://europepmc.org/abstract/MED/31819922
Type: Journal Article/Review
Volume: 2
Parent Publication: AAS open research
ISSN: 2515-9321